Key Takeaways
- Profit hit by own seed capital, not operations: Consolidated PAT fell sharply on a ₹65 crore mark-to-market loss in UTI International’s seed investments, while the core AMC’s operating income held up.
- Equity flows turned positive for the full year: Equity and hybrid net sales swung from negative ₹4,230 crores to positive ₹1,178 crores, and 57% of equity AUM now sits in the top two performance quartiles.
- Branch build-out is complete, costs now guided: 91 branches added in 15 months at net zero cost; management gave explicit FY26 opex and employee cost growth bands, signaling the investment phase is largely behind.
- Yield pressure is mild and partly offset: A 1–2 bps yield dilution from rising ETF mix will be cushioned by a recent distributor commission rationalization, the benefit of which starts next quarter.
- What to watch next quarter: Whether the multi-cap fund NFO gathers meaningful assets, the visible margin impact of the commission cut, and any stabilization in mark-to-market swings at UTI International.
The Mark-to-Market Drag
- Consolidated profit was bruised by UTI International: A ₹65 crore mark-to-market depreciation hit the consolidated P&L, concentrated in UTI Innovation Fund and UTI Dynamic Equity Fund, where UTI has placed seed capital. The AMC’s own balance sheet took only a ₹2 crore impact.
- Currency compounded the damage: Beyond market movement, the rupee’s sharp depreciation over the last year and especially in Q4 amplified the mark-to-market loss on international investments.
- Investment income collapsed: Other income dropped from ₹112 crores to ₹31 crores sequentially, driven almost entirely by the same seed-portfolio markdown. Operating income, by contrast, held steady.
- International AUM shrank on the same forces: The quarter-on-quarter and year-on-year decline in international AUM is a mark-to-market phenomenon in those two flagship funds, not a redemption story.
Imtaiyazur Rahman: “This is almost 94% of the stand-alone profit of the company, which is at ₹ 653 crores.”
Flow & Performance Turnaround
- Equity net sales flipped to positive: Full-year equity and hybrid net sales reached positive ₹1,178 crores, recovering from negative ₹4,230 crores in FY24, though the broader industry saw equity flows contract 14.4% MoM in March and 26.2% MoM in February as markets corrected.
- SIP engine kept compounding: Monthly SIP inflows rose marginally but continuously through FY25; full-year SIP inflows hit ₹8,325 crores, up 23% YoY, with SIP AUM growing 22.26% over the corresponding quarter.
- Fund performance is at an inflection point: 57% of equity and hybrid AUM is in the top two quartiles over one year, with three-month and six-month numbers even stronger. Management expects the strongest performance numbers to show up 18–24 months into the cycle, which is when gatekeepers’ three-year filters start to unlock market share gains.
- Hybrid and large-mid-cap funds gained traction: Net sales reflected good demand for hybrid funds, and the large and mid-cap fund also saw strong interest during the year.
- B30 cities remain a structural advantage: B30 cities contribute 22% of monthly average AUM versus an industry average of ~18%, a gap built through sustained presence in underserved regions.
Vetri Subramaniam: “In our experience, normally, you need at least a 12-month strong number to start turning the corner, which I think we saw in the last two quarters, we started to see that inflection point. And the strongest numbers typically show up 18 months, 24 months into the cycle because remember, for many people, including gatekeepers who approve products, typically, the 3-year number of performance is what actually plays a very critical role in their filtering.”
Cost Structure & Forward Guidance
- Q4 opex spike was branch-driven and non-recurring: The sharp Q4 increase reflects renovation and setup expenses for 91 branches opened over 15 months. On a full-year basis, other expenses rose only ~6% YoY as costs were rationalized elsewhere.
- FY26 other expenses guided to 7–8% growth: Management asked investors to model a 7–8% inflation increase on the full-year FY25 other-expenses base.
- Standalone employee cost growth capped at 300 bps: Despite a 7–8% annual wage hike, standalone employee cost is not expected to rise more than 300 bps over FY25, implying productivity offsets.
- Consolidated employee cost will run 150–200 bps higher: The extra spread comes from continued investment in subsidiaries, including UTI Pension’s planned addition of ~40 people.
- Capex should decline in FY26: With the branch expansion cycle largely complete, capex is expected to fall, though UTI Pension’s POP business expansion may add some incremental spend.
- Tax rate normalizes to 23–24%: The Q4 tax rate was elevated by ~2.3% due to a deferred tax liability change from the withdrawal of indexation benefit; the go-forward book rate is guided at 23–24%.
Yield, Margins & the Commission Cushion
- Yield dilution is capped at 1–2 bps: The expected dilution comes from a rising proportion of lower-yield ETF AUM, where inflows remain very strong.
- Distributor commission rationalization provides an offset: Older distributor commissions that had been weighing on margins for 4–5 years were rationalized this quarter. The benefit will begin to show in Q1 FY26 and is expected to cushion equity yield decline.
- Management declined to quantify the savings: When asked for a specific number, management said it is difficult to quantify and only offered the directional statement that it will provide a cushion.
Vinay Lakhotia: “We believe that rationalization will cushion some of the decline in the yield that may happen because of fresh inflows under equity and hybrid fund.”
Subsidiary & International Updates
- UTI Pension Fund is a quiet giant: AUM crossed ₹3.6 lakh crores, managing 24.86% of the NPS industry’s assets. Private-sector NPS AUM grew 61% YoY, and the fund absorbed all schemes from Max Life Pension Fund after a PFRDA-directed transfer based on strong performance.
- Market share in private NPS slipped slightly: The decline from 25.8% to 25% relates to the private sector, where share depends on marketing and sales capability rather than the pre-defined public-sector allocation.
- UTI Alternatives grew AUM 34% to ₹2,648 crores: Multiple funds are in fundraising, investing or exit stages, including the first Structured Debt Opportunities Fund which exited all investments profitably.
- UTI International is planting seeds: A new office opened in New York, the DIFC license in Dubai is being upgraded for advisory capabilities, and IFSC operations commenced with a USD 200 million commitment. Institutional engagement from global investors looking for India exposure is described as encouraging.
- International opex to grow at a similar run rate: FY26 operating expenses for UTI International are expected to track the current trajectory without a step-up.
Product & Distribution Levers
- Multi-cap fund NFO is the near-term catalyst: Regulatory approval is in hand, and the fund opened for subscription on 29th April. Beyond this, no diversified equity NFOs are in the pipeline; ETF and index fund launches will depend on appetite.
- Digital is now nearly half of equity and hybrid gross sales: 47.87% of gross sales in these categories were mobilized through digital platforms in Q4.
- Distribution empanelment widened significantly: Around 8,500 new MFD partners were added in FY25.
- Salesforce implementation went live: UTI became the first Indian mutual fund to deploy the Salesforce marketing automation tool for investors and MFDs, a capability that went live in FY25.
- 68 branches added at net zero cost: The expansion into Tier-2 and Tier-3 cities was funded by rationalizing space, reallocating people and modifying the branch organizational structure.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Other expenses growth | 7–8% inflation on FY25 full-year base | FY26 |
| Standalone employee cost growth | Not more than 300 bps over FY25, despite 7–8% wage hike | FY26 |
| Consolidated employee cost premium | 150–200 bps above standalone | FY26 |
| Tax rate | Book rate of 23–24% | Forward |
| Yield dilution | Maximum 1–2 bps, partly cushioned by commission rationalization | Forward |
| Capex | Should decline as branch expansion cycle ends | FY26 |
| UTI Pension headcount | ~40 additions to continue at similar run rate | Forward |
| UTI International opex | Grow at similar run rate to FY25 | FY26 |
| Market share inflection | Strongest performance numbers show up 18–24 months into the cycle, unlocking gatekeeper approvals | During FY26 |
Key Metrics
| Metric | Q4 FY25 |
|---|---|
| Consolidated core revenue from operations | ₹360 cr, up 13% YoY |
| Consolidated core PAT | ₹98 cr, up 2% YoY |
| Consolidated overall net profit | ₹731 cr (full year FY25), down 5% YoY |
| Standalone core revenue from operations | ₹296 cr, up 15% YoY |
| Standalone core PAT | ₹108 cr, up 20% YoY |
| Standalone overall net profit | ₹653 cr (full year FY25), up 9% YoY |
| Dividend per share | ₹48, including ₹22 special dividend, 94% of standalone profit |
| Mutual fund quarterly average AUM | ₹3.4 lakh cr, up 16.8% YoY |
| UTI Group total AUM | ₹21.05 lakh cr, up 14% YoY |
| Equity quarterly average AUM | ₹90,863 cr, up 7.18% YoY |
| Index and ETF funds quarterly average AUM | ₹1,41,492 cr, up 23% in Q4 |
| ETFs and Index fund net inflow | ₹19,605 cr |
| Equity and hybrid fund net sales (full year FY25) | ₹1,178 cr positive, vs negative ₹4,230 cr in FY24 |
| Market share of industry gross sales | 6.9% for Q4, 6.8% for full year FY25 |
| SIP AUM | ₹37,591 cr as of March 2025, up 22.26% YoY |
| SIP inflows for Q4 | ₹2,215 cr |
| SIP gross inflows YoY growth | 24%, average SIP ticket size ₹3,239 for March 2025 |
| SIP folios | 26.92 lakh in March 2025, up 14% YoY |
| B30 cities contribution to monthly average AUM | 22%, vs industry average of ~18% |
| Live folios | 1.33 cr, net addition of 1.89 lakh in Q4 |
| Equity AUM in top two quartiles (one-year period) | 57% |
| Weighted average book yield | ~34 bps; equity and hybrid ~75 bps, equity and index ~5-6 bps, cash ~9-10 bps, income fund ~22-23 bps |
| Expected yield dilution going forward | 1 to 2 bps max, mainly due to higher proportion of ETF AUM |
| Digital share of equity and hybrid gross sales | 47.87% in Q4 FY25 |
| New MFD partners added in FY25 | ~8,500 |
| Branches | 255 as of March 31, up from 164; 68 new branches in FY25 at net zero cost addition |
| UTI Pension Fund AUM | ~₹3.59 lakh cr, up 19% YoY; manages 24.86% of NPS industry AUM |
| UTI Pension Fund PAT (full year FY25) | ₹57 cr, up 5% YoY |
| UTI International AUM | ₹25,383 cr as of March 2025 |
| UTI Alternatives total AUM | ₹2,648 cr as of March 2025, up 34% YoY |
| Tax rate guidance (book rate) | 23% to 24% going forward |
| Standalone employee cost guidance for FY26 | Not to rise more than 300 bps over FY25, despite 7-8% wage hike |
| Consolidated employee cost guidance for FY26 | 150 to 200 bps higher than standalone, due to subsidiary investments |
| Other expenses growth guidance for FY26 | 7% to 8% inflation increase on overall FY25 number |